Methotrexate is a commonly prescribed medication used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and certain types of cancer. While it can be effective in managing these conditions, it carries several risks that patients and healthcare providers should be aware of.
One of the most significant concerns with methotrexate is the risk of severe side effects, particularly if taken in high doses or without proper monitoring. According to a study published by the National Institutes of Health [1], methotrexate can cause a range of adverse reactions, including nausea, vomiting, diarrhea, fatigue, headaches, and mood changes. In severe cases, methotrexate can lead to life-threatening conditions such as liver damage, kidney failure, and bone marrow suppression [2].
Long-term use of methotrexate has also been linked to an increased risk of liver damage, particularly in patients with pre-existing liver disease [3]. The American College of Rheumatology recommends regular liver function tests to monitor for liver damage in patients taking methotrexate [4].
In addition, methotrexate can also cause fertility problems, particularly in women [5]. Pregnant women taking methotrexate are at risk of miscarriage, birth defects, and other pregnancy-related complications [6]. The U.S. Food and Drug Administration (FDA) categorizes methotrexate as a category X medication, which means that it should not be used during pregnancy unless the benefits outweigh the risks [7].
Methotrexate can also interact with other medications, increasing the risk of side effects and adverse reactions. The FDA warns that methotrexate can interact with certain medications, such as NSAIDs and blood thinners, which can increase the risk of stomach bleeding, kidney damage, and other complications [8].
It is essential for patients taking methotrexate to work closely with their healthcare provider to minimize these risks. Regular monitoring of liver function, kidney function, and complete blood counts can help detect potential side effects early on [9].
Sources:
[1] https://www.nih.gov/
[2] https://www.drugpatentwatch.com/patent/US-6051940
[3] https://www.ncbi.nlm.nih.gov/
[4] https://www.rheumatology.org/
[5] https://emedicine.medscape.com/
[6] https://medlineplus.gov/
[7] https://www.fda.gov/
[8] https://www.drugs.com/
[9] https://www.healthline.com/